Aims and Objectives
Given the amount of research and investment in the field of novel diagnostics and biomarkers, it is predicted that provision of medicine in the future will be transformed. The main aims of novel diagnostics and biomarkers are not only to recognise infection and/or sepsis, but also to assist in triaging patients with regards to avoiding admission, ward admission, intensive care admission and even prognosis and predicting outcome.
Another aspect of novel diagnostics and biomarkers is to improve antibiotic stewardship in clinical settings. Therefore, this working group aims to:
- Organise educational meetings and provide educational material on the application of novel diagnostics and biomarkers in clinical practice e.g. antibiotic stewardship and/or triaging.
- Promote a “network” to collect data from those centres that use novel diagnostics and/or biomarkers and audits of good practice with regards to novel diagnostics and biomarkers.
- Develop practice guidelines or recommendations for a correct approach in applying these novel technologies and biomarkers in clinical practice.
We hope that the group’s work will result in a closer collaboration among international experts who can bridge the gap between studies, clinical applications and patients’ needs, thereby improving not only antibiotic stewardship and better quality of patient care, but also in reducing the cost to healthcare systems across the world.